YM2-21745-18013
2 vaccinations
6 coded responses
19 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 401 / KY
- Registered
- 2022-01-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-01-12
Dose 1 — Pfizer-BioNTech
-
2022-01-18
Registered in v-safe
-
2022-01-18
Survey response — days 1–6 daily, dose 1MedDRA: Adverse reaction — Feeling: Good · Muscle or body aches · Be unable to work or attend schoolFree text: I did have symptoms on Saturday, which was 3 days ago til yesterday (Monday).MedDRA releases: 2024-11 · check-in free text available
-
2022-01-19
Health check-in — day 7, dose 1Feeling: Fair · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-01-26
Survey response — day 14, dose 1MedDRA: Bronchitis, Nasal congestion, Pre-existing disease, Rhinorrhoea — Feeling: FairFree text: Just normal upper respiratory allergies that are normal for me at this time of year. Stuffy, watery nose with bronchitis. Just onset the past couple of days, no fever, no aches or soreness, and I can still taste and smell.MedDRA releases: 2024-11 · check-in free text available
-
2022-02-04
Survey response — day 21, dose 1MedDRA: Fatigue, Nausea, Paranasal sinus hypersecretion, Sinus headache — Feeling: PoorFree text: Sinus drainage, sinus headache, nauseated, and fatigueMedDRA releases: 2024-11 · check-in free text available
- 2022-02-09
-
2022-02-11
Dose 2 — Pfizer-BioNTech
-
2022-02-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Joint pains, Fatigue or tirednessAdult check-in
-
2022-02-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Swelling · Headache, Muscle or body aches, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
- 2022-02-14
- 2022-02-15
- 2022-02-16
- 2022-02-17
- 2022-02-18
- 2022-02-25
- 2022-03-04
-
2022-03-11
Survey response — day 28, dose 2MedDRA: Diarrhoea — Feeling: Poor · Be unable to work or attend schoolFree text: DiarrheaMedDRA releases: 2024-11 · check-in free text available
- 2022-03-18
-
2022-03-25
Survey response — day 42, dose 2MedDRA: Injection site erythema, Injection site scab — Feeling: FairFree text: The injection site was red and scabbed over until just last week. Shouldn't have even had a scab from a vaccine.MedDRA releases: 2024-11 · check-in free text available
- 2022-05-13
-
2023-02-11
Survey response — 12 months, dose 2MedDRA: COVID-19, Ear infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-02-11
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-02-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-01-12 | Pfizer-BioNTech | No |
| 2 | 2022-02-11 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2023-02-11 | Unsuccessful |
Free text
Release 10 — days 1–6 daily, dose 1
Systemic reaction (other): I did have symptoms on Saturday, which was 3 days ago til yesterday (Monday).
Release 11 — day 14, dose 1
Symptoms: Just normal upper respiratory allergies that are normal for me at this time of year. Stuffy, watery nose with bronchitis. Just onset the past couple of days, no fever, no aches or soreness, and I can still taste and smell.
Release 11 — day 21, dose 1
Symptoms: Sinus drainage, sinus headache, nauseated, and fatigue
Release 11 — day 28, dose 2
Symptoms: Diarrhea
Release 11 — day 42, dose 2
Symptoms: The injection site was red and scabbed over until just last week. Shouldn't have even had a scab from a vaccine.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Bronchitis | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Ear infection | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Injection site erythema | · | · | ✓ |
| SD | Injection site scab | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Paranasal sinus hypersecretion | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sinus headache | · | · | ✓ |
| SRO | Adverse reaction | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release